MAPT and Alzheimer disease: Relative to men, women show greater burdens of tau at equivalent levels of β amyloid (4, 5) and experience faster cognitive decline at comparable levels of AD pathology (i.e., β amyloid and tau), particularly after symptom onset (6, 7).